Literature DB >> 23082777

Long-term maintenance of normoglycaemia using everolimus in a patient with disseminated insulinoma and severe hypoglycaemia.

N J Thomas, A M Brooke, G M Besser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23082777     DOI： 10.1111/cen.12059

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  9 in total

Review 1.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

Review 2.  Management of functional neuroendocrine tumors of the pancreas.

Authors:  Kjell Öberg
Journal:  Gland Surg       Date:  2018-02

3.  Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2018-05-24       Impact factor: 3.889

4.  Spontaneous hypoglycemia: diagnostic evaluation and management.

Authors:  Leelavathy Kandaswamy; Rajeev Raghavan; Joseph M Pappachan
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

Review 5.  The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Authors:  M V Davi; A Pia; V Guarnotta; G Pizza; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2016-09-13       Impact factor: 4.256

6.  Metastatic insulinoma managed with radiolabeled somatostatin analog.

Authors:  Ricardo Costa; Rubens Costa; Carlos E Bacchi; Paulo Almeida Filho
Journal:  Case Rep Endocrinol       Date:  2013-12-17

7.  The Effect of Everolimus on Refractory Hypoglycemia in a Patient with Inoperable Metastatic Insulinoma Evaluated by Continuous Glucose Monitoring.

Authors:  Shingo Yanagiya; Kyu Yong Cho; Akinobu Nakamura; Hiroshi Nomoto; Yasuyuki Kawamoto; Kazumichi Kawakubo; Yoshito Komatsu; Tomoko Mitsuhashi; Hideaki Miyoshi; Tatsuya Atsumi
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

8.  A case of inoperable malignant insulinoma with resistant hypoglycemia who experienced the most significant clinical improvement with everolimus.

Authors:  Emre Bozkirli; Okan Bakiner; Huseyin Abali; Cagatay Andic; Ali Fuat Yapar; Fazilet Kayaselcuk; Eda Ertorer
Journal:  Case Rep Endocrinol       Date:  2013-05-08

9.  Sirolimus Therapy and Follow-up in a Patient with Severe Congenital Hyperinsulinism Following Subtotal Pancreatectomy

Authors:  Qiong Chen; Yongxing Chen; Xiaohong Wang; Haihua Yang; Yingxian Zhang; Xiaojing Liu; Yun Yan; Haiyan Wei
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.